אביטרקסט טבע

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

METHOTREXATE

थमां उपलब्ध:

ABIC MARKETING LTD, ISRAEL

ए.टी.सी कोड:

L01BA01

फार्मास्यूटिकल फॉर्म:

תמיסה להזרקה

रचना:

METHOTREXATE 25 MG/ML

प्रशासन का मार्ग:

תוך-שרירי, תוך-ורידי, תוך-שדרתי, תוך-עורקי, תוך חדרי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

PHARMACHEMIE B.V., (TEVA GROUP) ,THE NETHERLANDS

चिकित्सीय समूह:

METHOTREXATE

चिकित्सीय क्षेत्र:

METHOTREXATE

चिकित्सीय संकेत:

Antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. Palliation of acute lymphocytic leukemia. Abitrexate is also indicated in the treatment and prophylaxis of meningeal leukemia. Greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. In combination with other anticancer agents, Abitrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. Abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. Abitrexate is effective in the treatment of the advanced stages (III and IV Peter's Staging System) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. Psoriasis: because of the high risk attending its use, Abitrexate is

प्राधिकरण की तारीख:

2015-02-28